# Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

> **NCT03389100** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Columbia University** · enrollment: 600 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Pre-diabetes

## Interventions

- **DRUG:** 18F-MK6240 injection

## Key facts

- **NCT ID:** NCT03389100
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2018-07-24
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03389100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03389100, "Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03389100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*